Allison+Partners Expands Technology Practice’s U.S. Leadership Team
Key senior leads elevated as agency’s technology portfolio continues to grow globally and delivers strong…
Month: November 2022
Wolters Kluwer Compliance Solutions wins 2022 International Business Awards for product innovation
Cutting-edge technology, coupled with human compliance management expertise, lead to industry accolades MINNEAPOLIS–(BUSINESS WIRE)–#wolterskluwer—Wolters Kluwer…
Chia Network COO and President Gene Hoffman to Speak at FT Crypto and Digital Assets Summit
Leading blockchain & cryptocurrency expert will join regulators, industry leaders, and banking executives to discuss…
Lightopia Launches New Online Shopping Experience
Lightopia.com’s curated assortment is comprised of leading contemporary brands COSTA MESA, Calif.–(BUSINESS WIRE)–Lightopia, an omnichannel…
Oncotelic Reports Q3 2022 Compared to Q3 2021 Financial Results
R&D cost reduced in excess of 95% while continuing expansion of our OT-101 clinical programs…
Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and Trunk
WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…
Yield10 Bioscience to Present at the CG AgriFood Tech Innovation Virtual Forum
WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or…
Femasys Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference
ATLANTA, Nov. 21, 2022 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming…
Optinose Announces Pricing of Public Offering of Common Stock and Warrants
YARDLEY, Pa., Nov. 21, 2022 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on…
Cognition Therapeutics Launches Neuroscience Thought Leader Conversations Podcast/Webinar Series
PURCHASE, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company”…
Genmab Announces U.S. Food and Drug Administration Accepts for Priority Review Biologics License Application (BLA) for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL)
Media Release COPENHAGEN, Denmark; November 21, 2022 Epcoritamab BLA accepted for FDA Priority review; FDA…
TRACON Pharmaceuticals Announces Dosing of First Patient in Phase 1/2 Trial of YH001 in Combination with Envafolimab and Doxorubicin in Front Line Sarcoma
SAN DIEGO, Nov. 21, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical…
Umoja Biopharma and IASO Biotherapeutics Announce Research Collaboration to Bring Off-the-Shelf Therapies to Patients with Hematological Malignancies
Collaboration will bring together Umoja’s iCIL platform and IASO’s chimeric antigen receptors to create the…
Rhythm Pharmaceuticals Announces ▼IMCIVREE® (setmelanotide) Granted Marketing Authorization in Great Britain for Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome
— Health Canada accepts for review new drug submission for setmelanotide for the treatment of…
PDS Biotech Executives to Present an Overview of Oncology and Infectious Disease Programs at the World Vaccine & Immunotherapy Congress
Chief Medical Officer, Dr. Lauren V. Wood, to present on the development of targeted immunotherapies…
Athenex Announces Closing of the Sale of its China API Business
BUFFALO, N.Y., Nov. 21, 2022 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
Neurona Therapeutics Presents Encouraging Clinical Data from First-Ever Regenerative Human Cell Therapy Trial in Adults with Drug-Resistant Focal Epilepsy and Shows Supporting Manufacturing, Delivery, and Preclinical Data
Early data from the first two patients treated with NRTX-1001 report a trend toward seizure…
Ocuphire to Present at Five Upcoming Investor/Industry Conferences
FARMINGTON HILLS, Mich., Nov. 21, 2022 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
Blue Water Vaccines Announces Exclusive, Global License Agreement for Chlamydia Vaccine Candidate Development from The University of Texas Health San Antonio
CINCINNATI, Nov. 21, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
First Wave BioPharma, Inc. Announces Private Placement
BOCA RATON, Fla., Nov. 21, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First…